ProQR Therapeutics N.V. - ADR Financials

$1.84

$-0.02 (-1.08%)

As on 15-Sep-2026 16:00EDT

Market cap

$262 Mln

Revenue (TTM)

$19 Mln

P/E Ratio

--

P/B Ratio

3

Div. Yield

0 %

Annual
Quarterly

Cashflow (€ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-52.79	-36.39	21.55	-68.51	-26.01
Cash Flow from Investing Activities	--	-1.02	-4.07	4.28	-0.70	-0.43
Cash from Financing Activities	--	-1.84	70.28	-2.28	-30.89	136.83
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS (€)	-0.40	-0.39	-0.34	-0.36	-0.83	-0.85
Cash EPS (€)	--	-0.37	-0.31	-0.33	-0.80	-0.82
Adjusted Book Value (€)	--	0.56	1.12	0.58	0.92	1.82
Dividend per Share (€)	--	--	--	--	--	--
Cash Flow per Share (€)	--	-0.51	-0.45	0.27	-0.89	-0.37
Free Cash Flow per Share (€)	--	-0.52	-0.46	0.26	-0.89	-0.37

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-44.48	-31.67	-34.60	-43.96	-39.20
ROE (%)	-65.71	-54.14	-40.40	-47.95	-64.10	-60.95
ROA (%)	-22.01	-26.45	-17.02	-16.78	-30.59	-33.83
EBIT Margin (%)	-229.99	-259.42	-142.20	-408.50	-1,641.10	-4,290.41
Net Margin (%)	-228.38	-265.21	-146.86	-431.67	-1,792.54	-4,549.81
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	12.40	-0.19	1.90	0.81	1.69	0.30
EBIT Growth (%)	-13.38	-47.43	-1.03	54.88	-2.98	-12.77
Net Profit Growth (%)	-6.67	-45.95	1.27	56.35	-6.07	-30.44
EPS Growth (%)	6.83	-0.16	0.05	0.57	0.02	0.08
Book Value Growth (%)	-3.20	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.28	0.18	0.48	0.33	0.53
Short term debt to equity ratio	0.06	0.09	0.05	0.04	0.06	0.06
Current Ratio	3.49	3.09	3.95	3.54	7.36	6.94
Quick Ratio	3.49	--	--	3.54	7.36	6.93
Interest Coverage	--	-45.75	-24.96	-22.12	-11.50	-16.82

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	10.03	39.10	11.10	21.50	1,699.64	70.11
Asset Turnover	0.10	0.10	0.12	0.04	0.02	0.01
Receivable days	--	96.49	33.81	1,751.84	3,151.53	261.93
Inventory Days	--	--	--	9.39	20.16	--
Payable days	--	25.78	--	2,900.45	46.89	--
Cash Conversion Cycle	--	--	--	-1,139.22	3,124.81	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.